{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:56:14Z","timestamp":1794956174550,"version":"4.9.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"8095","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Stem-like progenitors are self-renewing cytotoxic T cells that expand as effector cells during successful checkpoint immunotherapy\n                    <jats:sup>1,2<\/jats:sup>\n                    . Emerging evidence suggests that tumour-draining lymph nodes support the continuous generation of these stem-like cells that replenish tumour sites and are a key source of expanded effector populations\n                    <jats:sup>3\u20136<\/jats:sup>\n                    , underlining the importance of understanding what factors promote and maintain activated T cells in the stem-like state. Here, using advanced three-dimensional multiplex immunofluorescence imaging, we identify antigen-presentation niches in tumour-draining lymph nodes that support the expansion, maintenance and affinity evolution of TCF-1\n                    <jats:sup>+<\/jats:sup>\n                    PD-1\n                    <jats:sup>+<\/jats:sup>\n                    SLAMF6\n                    <jats:sup>high<\/jats:sup>\n                    stem-like CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Contrary to the prevailing view that persistent T cell receptor (TCR) signalling drives terminal effector differentiation, prolonged antigen engagement days beyond initial priming sustains the proliferation and self-renewal of these stem-like T cells in vivo. The inhibitory PD-1 pathway has a central role in this process through fine-tuning the TCR signal input that enables the selective expansion of high-affinity TCR stem-like clones as a renewable source of effector cells. PD-1 blockade disrupts this tuning, leading to terminal differentiation or death of the most avid anti-tumour stem-like cells. Our results therefore reveal a relationship between TCR ligand affinity recognition, a key negative-feedback regulatory loop and T cell stemness programming. Furthermore, these findings raise questions about whether anti-PD-1 blockade during cancer immunotherapy provides a short-term anti-tumour effect at the cost of diminishing efficacy due to progressive loss of these critical high-affinity precursors.\n                  <\/jats:p>","DOI":"10.1038\/s41586-025-09440-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:04:06Z","timestamp":1764173046000},"page":"194-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Inhibitory PD-1 axis maintains high-avidity stem-like CD8+ T cells"],"prefix":"10.1038","volume":"649","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6721-4204","authenticated-orcid":false,"given":"Jyh Liang","family":"Hor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1793-6433","authenticated-orcid":false,"given":"Edward C.","family":"Schrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3249-9323","authenticated-orcid":false,"given":"Abigail","family":"Wong-Rolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Vistain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0646-7946","authenticated-orcid":false,"given":"Wanjing","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1494-5983","authenticated-orcid":false,"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-9143","authenticated-orcid":false,"given":"Ronald N.","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"9440_CR1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41590-022-01219-w","volume":"23","author":"D Zehn","year":"2022","unstructured":"Zehn, D., Thimme, R., Lugli, E., de Almeida, G. P. & Oxenius, A. \u2018Stem-like\u2019 precursors are the fount to sustain persistent CD8+ T cell responses. Nat. Immunol. 23, 836\u2013847 (2022).","journal-title":"Nat. Immunol."},{"key":"9440_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","volume":"50","author":"I Siddiqui","year":"2019","unstructured":"Siddiqui, I. et al. Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity 50, 195\u2013211 (2019).","journal-title":"Immunity"},{"key":"9440_CR3","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg7836","volume":"6","author":"KA Connolly","year":"2021","unstructured":"Connolly, K. A. et al. A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci. Immunol. 6, eabg7836 (2021).","journal-title":"Sci. Immunol."},{"key":"9440_CR4","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.immuni.2021.08.026","volume":"54","author":"JM Schenkel","year":"2021","unstructured":"Schenkel, J. M. et al. Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes. Immunity 54, 2338\u20132353 (2021).","journal-title":"Immunity"},{"key":"9440_CR5","doi-asserted-by":"crossref","unstructured":"Li, Z. et al. In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue. J. Exp. Med. 219, e20210749 (2022).","DOI":"10.1084\/jem.20210749"},{"key":"9440_CR6","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","volume":"186","author":"MK Rahim","year":"2023","unstructured":"Rahim, M. K. et al. Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell 186, 1127\u20131143 (2023).","journal-title":"Cell"},{"key":"9440_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","volume":"18","author":"AH Sharpe","year":"2018","unstructured":"Sharpe, A. H. & Pauken, K. E. The diverse functions of the PD1 inhibitory pathway. Nat. Rev. Immunol. 18, 153\u2013167 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"9440_CR8","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas, A. & Wolchok, J. D. Cancer immunotherapy using checkpoint blockade. Science 359, 1350\u20131355 (2018).","journal-title":"Science"},{"key":"9440_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi, S., Yuan, R. & Engleman, E. G. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Annu. Rev. Pathol. 16, 223\u2013249 (2021).","journal-title":"Annu. Rev. Pathol."},{"key":"9440_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.it.2019.11.004","volume":"41","author":"E Lugli","year":"2020","unstructured":"Lugli, E., Galletti, G., Boi, S. K. & Youngblood, B. A. Stem, effector, and hybrid states of memory CD8+ T cells. Trends Immunol. 41, 17\u201328 (2020).","journal-title":"Trends Immunol."},{"key":"9440_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature19330","volume":"537","author":"SJ Im","year":"2016","unstructured":"Im, S. J. et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537, 417\u2013421 (2016).","journal-title":"Nature"},{"key":"9440_CR12","first-page":"E7321","volume":"114","author":"W Li","year":"2017","unstructured":"Li, W., Germain, R. N. & Gerner, M. Y. Multiplex, quantitative cellular analysis in large tissue volumes with clearing-enhanced 3D microscopy (Ce3D). Proc. Natl Acad. Sci. USA 114, E7321\u2013E7330 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9440_CR13","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.4049\/jimmunol.1102661","volume":"188","author":"MK Jenkins","year":"2012","unstructured":"Jenkins, M. K. & Moon, J. J. The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude. J. Immunol. 188, 4135\u20134140 (2012).","journal-title":"J. Immunol."},{"key":"9440_CR14","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/nprot.2009.95","volume":"4","author":"M DuPage","year":"2009","unstructured":"DuPage, M., Dooley, A. L. & Jacks, T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat. Protoc. 4, 1064\u20131072 (2009).","journal-title":"Nat. Protoc."},{"key":"9440_CR15","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.4049\/jimmunol.1202798","volume":"190","author":"C Yamazaki","year":"2013","unstructured":"Yamazaki, C. et al. Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1. J. Immunol. 190, 6071\u20136082 (2013).","journal-title":"J. Immunol."},{"key":"9440_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nature02238","volume":"427","author":"TR Mempel","year":"2004","unstructured":"Mempel, T. R., Henrickson, S. E. & Von Andrian, U. H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427, 154\u2013159 (2004).","journal-title":"Nature"},{"key":"9440_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41590-021-00878-5","volume":"22","author":"BC Duckworth","year":"2021","unstructured":"Duckworth, B. C. et al. Effector and stem-like memory cell fates are imprinted in distinct lymph node niches directed by CXCR3 ligands. Nat. Immunol. 22, 434\u2013448 (2021).","journal-title":"Nat. Immunol."},{"key":"9440_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.immuni.2012.09.012","volume":"38","author":"F Marangoni","year":"2013","unstructured":"Marangoni, F. et al. The transcription factor NFAT exhibits signal memory during serial T cell interactions with antigen-presenting cells. Immunity 38, 237\u2013249 (2013).","journal-title":"Immunity"},{"key":"9440_CR19","doi-asserted-by":"publisher","unstructured":"Maltez, V. et al. Agonistic anti-CD40 converts Tregs into type 1 effectors within the tumor micro-environment. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.10.17.512537 (2022).","DOI":"10.1101\/2022.10.17.512537"},{"key":"9440_CR20","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s41590-024-01843-8","volume":"25","author":"X Lan","year":"2024","unstructured":"Lan, X. et al. Antitumor progenitor exhausted CD8+ T cells are sustained by TCR engagement. Nat. Immunol. 25, 1046\u20131058 (2024).","journal-title":"Nat. Immunol."},{"key":"9440_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl4492","volume":"386","author":"TG Kang","year":"2024","unstructured":"Kang, T. G. et al. Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy. Science 386, eadl4492 (2024).","journal-title":"Science"},{"key":"9440_CR22","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","volume":"114","author":"M Ahmadzadeh","year":"2009","unstructured":"Ahmadzadeh, M. et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114, 1537\u20131544 (2009).","journal-title":"Blood"},{"key":"9440_CR23","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326\u2013336 (2019).","journal-title":"Nat. Immunol."},{"key":"9440_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","volume":"557","author":"Y Simoni","year":"2018","unstructured":"Simoni, Y. et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575\u2013579 (2018).","journal-title":"Nature"},{"key":"9440_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113279","volume":"42","author":"DG Chen","year":"2023","unstructured":"Chen, D. G., Xie, J., Su, Y. & Heath, J. R. T cell receptor sequences are the dominant factor contributing to the phenotype of CD8+ T cells with specificities against immunogenic viral antigens. Cell Rep. 42, 113279 (2023).","journal-title":"Cell Rep."},{"key":"9440_CR26","doi-asserted-by":"publisher","first-page":"23799","DOI":"10.1074\/jbc.M700976200","volume":"282","author":"B Laugel","year":"2007","unstructured":"Laugel, B. et al. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties. J. Biol. Chem. 282, 23799\u201323810 (2007).","journal-title":"J. Biol. Chem."},{"key":"9440_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3389\/fimmu.2015.00617","volume":"6","author":"MA Daniels","year":"2015","unstructured":"Daniels, M. A. & Teixeiro, E. TCR signaling in T cell memory. Front. Immunol. 6, 617 (2015).","journal-title":"Front. Immunol."},{"key":"9440_CR28","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1084\/jem.20142237","volume":"212","author":"PM Odorizzi","year":"2015","unstructured":"Odorizzi, P. M., Pauken, K. E., Paley, M. A., Sharpe, A. & Wherry, E. J. Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells. J. Exp. Med. 212, 1125\u20131137 (2015).","journal-title":"J. Exp. Med."},{"key":"9440_CR29","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1073\/pnas.1718217115","volume":"115","author":"E Ahn","year":"2018","unstructured":"Ahn, E. et al. Role of PD-1 during effector CD8 T cell differentiation. Proc. Natl Acad. Sci. USA 115, 4749\u20134754 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9440_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","volume":"51","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision. Immunity 51, 840\u2013855 (2019).","journal-title":"Immunity"},{"key":"9440_CR31","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.4049\/jimmunol.172.4.2530","volume":"172","author":"K Matsumoto","year":"2004","unstructured":"Matsumoto, K. et al. B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism. J. Immunol. 172, 2530\u20132541 (2004).","journal-title":"J. Immunol."},{"key":"9440_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/mab.2021.0068","volume":"41","author":"MT Bu","year":"2022","unstructured":"Bu, M. T., Yuan, L., Klee, A. N. & Freeman, G. J. A comparison of murine PD-1 and PD-L1 monoclonal antibodies. Monoclon. Antib. Immunodiagn. Immunother. 41, 202\u2013209 (2022).","journal-title":"Monoclon. Antib. Immunodiagn. Immunother."},{"key":"9440_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20112741","volume":"209","author":"T Yokosuka","year":"2012","unstructured":"Yokosuka, T. et al. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J. Exp. Med. 209, 1201\u20131217 (2012).","journal-title":"J. Exp. Med."},{"key":"9440_CR34","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.celrep.2012.10.015","volume":"2","author":"KR Garrod","year":"2012","unstructured":"Garrod, K. R. et al. Dissecting T cell contraction in vivo using a genetically encoded reporter of apoptosis. Cell Rep. 2, 1438\u20131447 (2012).","journal-title":"Cell Rep."},{"key":"9440_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1034\/j.1600-065X.2003.00051.x","volume":"193","author":"DR Green","year":"2003","unstructured":"Green, D. R., Droin, N. & Pinkoski, M. Activation-induced cell death in T cells. Immunol. Rev. 193, 70\u201381 (2003).","journal-title":"Immunol. Rev."},{"key":"9440_CR36","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1002\/eji.200324228","volume":"33","author":"SC Liang","year":"2003","unstructured":"Liang, S. C. et al. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33, 2706\u20132716 (2003).","journal-title":"Eur. J. Immunol."},{"key":"9440_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s42003-021-02111-3","volume":"4","author":"T Takehara","year":"2021","unstructured":"Takehara, T. et al. PD-L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment. Commun. Biol. 4, 581 (2021).","journal-title":"Commun. Biol."},{"key":"9440_CR38","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1126\/science.aav7062","volume":"364","author":"D Sugiura","year":"2019","unstructured":"Sugiura, D. et al. Restriction of PD-1 function by cis-PD-L1\/CD80 interactions is required for optimal T cell responses. Science 364, 558\u2013566 (2019).","journal-title":"Science"},{"key":"9440_CR39","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1084\/jem.20130790","volume":"211","author":"Y Xiao","year":"2014","unstructured":"Xiao, Y. et al. RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance. J. Exp. Med. 211, 943\u2013959 (2014).","journal-title":"J. Exp. Med."},{"key":"9440_CR40","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1126\/science.1227049","volume":"338","author":"L Pace","year":"2012","unstructured":"Pace, L. et al. Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory. Science 338, 532\u2013536 (2012).","journal-title":"Science"},{"key":"9440_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature07657","volume":"458","author":"D Zehn","year":"2009","unstructured":"Zehn, D., Lee, S. Y. & Bevan, M. J. Complete but curtailed T-cell response to very low-affinity antigen. Nature 458, 211\u2013214 (2009).","journal-title":"Nature"},{"key":"9440_CR42","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1158\/2326-6066.CIR-22-0761","volume":"11","author":"ZLZ Hay","year":"2023","unstructured":"Hay, Z. L. Z., Knapp, J. R., Magallon, R. E., O\u2019Connor, B. P. & Slansky, J. E. Low TCR binding strength results in increased progenitor-like CD8+ tumor-infiltrating lymphocytes. Cancer Immunol. Res. 11, 570\u2013582 (2023).","journal-title":"Cancer Immunol. Res."},{"key":"9440_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","volume":"56","author":"N Prokhnevska","year":"2023","unstructured":"Prokhnevska, N. et al. CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor. Immunity 56, 107\u2013124 (2023).","journal-title":"Immunity"},{"key":"9440_CR44","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1126\/science.aaf1292","volume":"355","author":"E Hui","year":"2017","unstructured":"Hui, E. et al. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science 355, 1428\u20131433 (2017).","journal-title":"Science"},{"key":"9440_CR45","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.aaf0683","volume":"355","author":"AO Kamphorst","year":"2017","unstructured":"Kamphorst, A. O. et al. Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent. Science 355, 1423\u20131427 (2017).","journal-title":"Science"},{"key":"9440_CR46","doi-asserted-by":"crossref","unstructured":"Chan, W. et al. TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathways. J. Exp. Med. 220, e20231242 (2023).","DOI":"10.1084\/jem.20231242"},{"key":"9440_CR47","doi-asserted-by":"crossref","unstructured":"Chu, T. et al. Precursors of exhausted T cells are preemptively formed in acute infection. Nature 640, 782\u2013792 (2025).","DOI":"10.1038\/s41586-024-08451-4"},{"key":"9440_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1074-7613(01)00259-X","volume":"16","author":"JG Egen","year":"2002","unstructured":"Egen, J. G. & Allison, J. P. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16, 23\u201335 (2002).","journal-title":"Immunity"},{"key":"9440_CR49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.immuni.2013.11.017","volume":"40","author":"T Honda","year":"2014","unstructured":"Honda, T. et al. Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues. Immunity 40, 235\u2013247 (2014).","journal-title":"Immunity"},{"key":"9440_CR50","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med. 25, 1251\u20131259 (2019).","journal-title":"Nat. Med."},{"key":"9440_CR51","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s43018-019-0022-x","volume":"1","author":"S Valpione","year":"2020","unstructured":"Valpione, S. et al. Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy. Nat. Cancer 1, 210\u2013221 (2020).","journal-title":"Nat. Cancer"},{"key":"9440_CR52","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1016\/j.cell.2022.06.018","volume":"185","author":"AM Luoma","year":"2022","unstructured":"Luoma, A. M. et al. Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy. Cell 185, 2918\u20132935 (2022).","journal-title":"Cell"},{"key":"9440_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110331","volume":"38","author":"J Nagasaki","year":"2022","unstructured":"Nagasaki, J. et al. PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes. Cell Rep. 38, 110331 (2022).","journal-title":"Cell Rep."},{"key":"9440_CR54","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm.3910","volume":"21","author":"AP Rapoport","year":"2015","unstructured":"Rapoport, A. P. et al. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nat. Med. 21, 914\u2013921 (2015).","journal-title":"Nat. Med."},{"key":"9440_CR55","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-021-03752-4","volume":"596","author":"JX Caushi","year":"2021","unstructured":"Caushi, J. X. et al. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature 596, 126\u2013132 (2021).","journal-title":"Nature"},{"key":"9440_CR56","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41586-022-05531-1","volume":"615","author":"SP Foy","year":"2023","unstructured":"Foy, S. P. et al. Non-viral precision T cell receptor replacement for personalized cell therapy. Nature 615, 687\u2013696 (2023).","journal-title":"Nature"},{"key":"9440_CR57","doi-asserted-by":"crossref","unstructured":"Shakiba, M. et al. TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion. J. Exp. Med. 219, e20201966 (2022).","DOI":"10.1084\/jem.20201966"},{"key":"9440_CR58","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1440-1711.2003.01191.x","volume":"81","author":"JM Murray","year":"2003","unstructured":"Murray, J. M. et al. Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty. Immunol. Cell Biol. 81, 487\u2013495 (2003).","journal-title":"Immunol. Cell Biol."},{"key":"9440_CR59","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.immuni.2012.02.006","volume":"36","author":"I den Braber","year":"2012","unstructured":"den Braber, I. et al. Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity 36, 288\u2013297 (2012).","journal-title":"Immunity"},{"key":"9440_CR60","doi-asserted-by":"crossref","unstructured":"Perdyan, A. et al. The effectiveness of cancer immune checkpoint inhibitor retreatment and rechallenge\u2014a systematic review. Cancers 15, 3490 (2023).","DOI":"10.3390\/cancers15133490"},{"key":"9440_CR61","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nbt.3235","volume":"33","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat. Biotechnol. 33, 661\u2013667 (2015).","journal-title":"Nat. Biotechnol."},{"key":"9440_CR62","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41596-019-0156-4","volume":"14","author":"W Li","year":"2019","unstructured":"Li, W., Germain, R. N. & Gerner, M. Y. High-dimensional cell-level analysis of tissues with Ce3D multiplex volume imaging. Nat. Protoc. 14, 1708\u20131733 (2019).","journal-title":"Nat. Protoc."},{"key":"9440_CR63","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41596-021-00644-9","volume":"17","author":"AJ Radtke","year":"2022","unstructured":"Radtke, A. J. et al. IBEX: an iterative immunolabeling and chemical bleaching method for high-content imaging of diverse tissues. Nat. Protoc. 17, 378\u2013401 (2022).","journal-title":"Nat. Protoc."},{"key":"9440_CR64","doi-asserted-by":"crossref","unstructured":"Weigert, M., Schmidt, U., Haase, R., Sugawara, K. & Myers, G. Star-convex polyhedra for 3D object detection and segmentation in microscopy. In Proc. 2020 IEEE Winter Conference on Applications of Computer Vision (WACV) 3655\u20133662 (IEEE, 2020).","DOI":"10.1109\/WACV45572.2020.9093435"},{"key":"9440_CR65","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 100\u2013106 (2021).","journal-title":"Nat. Methods"},{"key":"9440_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-1-60761-421-0_14","volume":"595","author":"D Vremec","year":"2010","unstructured":"Vremec, D. The isolation of mouse dendritic cells from lymphoid tissues and the identification of dendritic cell subtypes by multiparameter flow cytometry. Methods Mol. Biol. 595, 205\u2013229 (2010).","journal-title":"Methods Mol. Biol."},{"key":"9440_CR67","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-018-0812-9","volume":"565","author":"SL Park","year":"2019","unstructured":"Park, S. L. et al. Tissue-resident memory CD8+ T cells promote melanoma-immune equilibrium in skin. Nature 565, 366\u2013371 (2019).","journal-title":"Nature"},{"key":"9440_CR68","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S1074-7613(00)80572-5","volume":"8","author":"F Crawford","year":"1998","unstructured":"Crawford, F., Kozono, H., White, J., Marrack, P. & Kappler, J. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8, 675\u2013682 (1998).","journal-title":"Immunity"},{"key":"9440_CR69","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S1074-7613(00)80048-5","volume":"10","author":"PA Savage","year":"1999","unstructured":"Savage, P. A., Boniface, J. J. & Davis, M. M. A kinetic basis for T cell receptor repertoire selection during an immune response. Immunity 10, 485\u2013492 (1999).","journal-title":"Immunity"},{"key":"9440_CR70","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S1097-2765(03)00474-X","volume":"12","author":"M Krogsgaard","year":"2003","unstructured":"Krogsgaard, M. et al. Evidence that structural rearrangements and\/or flexibility during TCR binding can contribute to T cell activation. Mol. Cell 12, 1367\u20131378 (2003).","journal-title":"Mol. Cell"},{"key":"9440_CR71","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.1073\/pnas.1221609110","volume":"110","author":"S Zhong","year":"2013","unstructured":"Zhong, S. et al. T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy. Proc. Natl Acad. Sci. USA 110, 6973\u20136978 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"9440_CR72","doi-asserted-by":"publisher","unstructured":"Hor, J. L. et al. Data for \u2018Inhibitory PD-1 axis maintains high-avidity stem-like CD8+ T cells\u2019. Zenodo https:\/\/doi.org\/10.5281\/zenodo.15599321 (2025).","DOI":"10.5281\/zenodo.15599321"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09440-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09440-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09440-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:04:47Z","timestamp":1766534687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09440-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":72,"journal-issue":{"issue":"8095","published-print":{"date-parts":[[2026,1,1]]}},"alternative-id":["9440"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09440-x","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}